Compare TTEC & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TTEC | NBY |
|---|---|---|
| Founded | 1982 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.4M | 398.2M |
| IPO Year | 1996 | 2007 |
| Metric | TTEC | NBY |
|---|---|---|
| Price | $3.49 | $4.43 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $3.50 | N/A |
| AVG Volume (30 Days) | 367.4K | ★ 2.3M |
| Earning Date | 11-06-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.47 |
| Revenue | ★ $2,134,379,000.00 | $10,302,000.00 |
| Revenue This Year | N/A | $23.91 |
| Revenue Next Year | N/A | $32.05 |
| P/E Ratio | ★ N/A | $210.99 |
| Revenue Growth | N/A | ★ 390.34 |
| 52 Week Low | $2.49 | $0.46 |
| 52 Week High | $5.60 | $6.47 |
| Indicator | TTEC | NBY |
|---|---|---|
| Relative Strength Index (RSI) | 47.51 | 69.46 |
| Support Level | $3.56 | $2.92 |
| Resistance Level | $3.72 | $6.47 |
| Average True Range (ATR) | 0.19 | 0.85 |
| MACD | -0.03 | 0.32 |
| Stochastic Oscillator | 0.19 | 63.00 |
TTEC Holdings Inc provides customer engagement management tools and services. The company operates through four operating segments that are organized into two groups, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its sales are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.